Redwood Banner
Search Icon

At Redwood Bio, we are detecting viral biomarkers at its earliest stage and thereby revolutionizing treatment of devastating disease. Imagine a world where a simple blood test has the power to detect multiple viral diseases?

Technology Icon

At Redwood Bio, we are turning this imagination into reality through our groundbreaking assay technology.

Revolutionary Technology: Enables Early Diagnosis with Unparalleled Sensitivity & Reliability

What sets Redwood Bio apart is our unique assay principle and detection technology that detects biomarkers unmeasured by other technologies.

With a sensitivity 100,000 fold greater than ELISA (the gold standard), we enable clinicians to delve deeper into the complexities of blood biomarkers, gaining valuable insights into early detection, and potential treatment approaches.


Check Mark
Validated breakthrough technology, consistently achieving attomolar detection levels with exceptional sensitivity and reliability
Revolutionary Technology
Content

Democratizing access to ultrasensitive early-stage disease detection

At Redwood, our technology is democratizing access to ultrasensitive early-stage disease detection.

Redwood’s revolutionary technology achieves what is considered unattainable performance in medical diagnostics. It enables early detection of HCV and other biomarkers
Shattering the glass ceiling in diagnostics and setting the standard for next-gen healthcare

When we emphasize the democratization of accurate early viral biomarkers detection and diagnosis, we mean it!

Icon

Consistent Precision


Our technology ensures reliable results, minimizing variability and guaranteeing reproducibility. Crucial for accurate diagnosis, research, and clinical decision-making.

Icon

Simple Workflow


Our assay technology offers a simplified workflow, minimizing the need for complicated instrumentation or technical expertise. This user-friendly approach makes it accessible to a wide range of users, including clinicians and researchers.

Icon

Biomarker Agnostic


Our technology is biomarker agnostic, detecting over 96 biomarkers. This versatility empowers researchers and clinicians to explore diverse disease indications and customize their assays accordingly.

Icon

Translation into Clinical Assays


Our assay technology is deployable at the point-of-care, offering swift on-site diagnostics. This allows for timely interventions, enhances patient care, and supports decentralized testing.

Paradigm-shifting Assay Technology
Search Icon

We have achieved unprecedented levels of sensitivity and reliability, surpassing the limitations of traditional diagnostic methods. With this unrivaled sensitivity, we empower clinicians to detect the earliest signs of viral diseases, leading to timely interventions and optimized treatment strategies.

Redwood Surpasses Competitors with Precision & Early Detection

Our blood test achieves what is considered unattainable in medical diagnostics: broad dynamic range, high sensitivity, and low-cost

Redwood's Innovative Leap

Our instrument overcomes the complexity vs sensitivity trade-off

Innovative leap

_

ONE ASSAY

unparalled performance

update

Low cost

update

9-log Dynamic Range

update

High Sensitivity

update

Small Form Factor

update

Quantitative Detection

update

High-throughput

Advancement

  A new age for early disease detection and advancements in diagnostic precision

Unprecedented dynamic range

Unprecedented dynamic range (9 log)


Our ability to identify biomarkers across a broad prevalence spectrum not only empowers clinicians for early diagnosis but will also facilitate identification of the disease's stage/maturity which will change the face of patient care and treatment truly setting us apart from our competitors.

Exceptional Attomolar Sensitivity

Exceptional Attomolar Sensitivity (10-18)


Redwood's attomolar sensitivity represents a significant advancement in medical diagnostics, offering early detection, improved accuracy, and precise disease management.

Extraordinary Quantification Capability

Extraordinary Quantification Capability


Observing subtle biomarker fluctuations and their quantities, as a result of our unparalleled dynamic range, provides key insight into disease progression and success of treatment on the patient.

Multiplexing

Multiplexing


There is no silver bullet in the diagnosis of Alzheimer’s and as a result our ability to detect multiple biomarkers simultaneously aids a conclusive diagnosis. However, this in of itself is not what sets us apart. Our dynamic range enables our multiplexing to be unlike any other in its ability to detect not only low concentrations of biomarkers but capturing their change and quantification over time which is crucial to an accurate diagnosis of the stage of the disease.

Fraction of Cost

Fraction of Cost


Low instrument cost and low per-test expense expands market reach while maintaining profitability.

Scalable

Scalable


Redwood's scalable solution for central labs and point-of-care customers, overcomes the complexities of traditional methods like mass spectrometry and single-molecule counting.

Redwood’s Unmatched Biomarker Capabilities

Redwood's Unmatched Biomarker Capabilities

Biomarker

Redwood’s disruptive technology enables detection of ultra-low abundance viral disease biomarkers, even at attomolar levels, outperforming market-leading instruments.

The most exciting aspect is that these capabilities have been validated through the utilization of actual patient samples, meaning the prospect of early detection with increased accuracy before symptoms manifest is on the horizon.

Demonstrated detection of multiple viral biomarkers at attomolar concentrations
Quantitative detection capability over 6 or 9-log dynamic range
Linear response curve
100x higher LOD and LLOQ from the closest competitor
No need for special reagents
~1,000,000-fold increased sensitivity with respect to manufacturer claimed pM. shown to ELISA kit manufacturer
8-plex measurements
Scalable approach
RedwoodBio Learn More

Revolutionize diagnostics with Redwood Bio!

âś–